Detalhe da pesquisa
1.
PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens.
Nature
; 619(7968): 151-159, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344588
2.
Multi-center retrospective review of vitiligo-like lesions in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors.
Breast Cancer Res Treat
; 204(3): 643-647, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38224427
3.
INDIVIDUAL ARTICLE: USCOM Algorithm for the Prevention and Management of Cutaneous Immunotherapy-Related Adverse Events.
J Drugs Dermatol
; 22(11): SF389716s3-SF389716s10, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37943279
4.
United States Cutaneous Oncodermatology Management (USCOM) II: A Multidisciplinary-Guided Algorithm for the Prevention and Management of Acute Radiation Dermatitis in Cancer Patients.
J Drugs Dermatol
; 21(11): SF3585693-SF35856914, 2022 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342740
5.
Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines.
Oncologist
; 26(2): e316-e326, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33021006
6.
US Cutaneous Oncodermatology Management (USCOM): A Practical Algorithm.
J Drugs Dermatol
; 20(9): 3ss-s19, 2021 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34491030
7.
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.
J Am Acad Dermatol
; 82(3): 612-621, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31185230
8.
Topical cholesterol/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy.
J Am Acad Dermatol
; 82(1): 123-131, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31449901
9.
Cutaneous Toxicities of Immune Checkpoint Inhibitors: The Role of the Dermatologist.
Yale J Biol Med
; 93(1): 123-132, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32226342
10.
Inflammatory eruptions associated with immune checkpoint inhibitor therapy: A single-institution retrospective analysis with stratification of reactions by toxicity and implications for management.
J Am Acad Dermatol
; 80(4): 990-997, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30399387
11.
Lobular neutrophilic panniculitis associated with DNA methyltransferase inhibitors in the treatment of myeloid disease.
J Cutan Pathol
; 46(12): 930-934, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31254406
12.
Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy: reply from the authors.
Br J Dermatol
; 190(1): 138, 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37947404
13.
Immune checkpoint inhibitor-induced bullous pemphigoid is characterized by interleukin (IL)-4 and IL-13 expression and responds to dupilumab treatment.
Br J Dermatol
; 189(3): 339-341, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37140007
14.
The effect of baseline eczema or psoriasis on the morphology of cutaneous immune-related adverse events due to immune checkpoint inhibitor therapy.
J Am Acad Dermatol
; 88(5): 1198-1200, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634749
15.
The spectrum of cutaneous immune-related adverse events in patients with skin of color.
J Am Acad Dermatol
; 88(5): 1156-1158, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470309
16.
Malignant blue nevus: Characterization of US epidemiology and prognostic factors of a rare neoplasm with aggressive clinical course using the Surveillance, Epidemiology, and End Results Program database.
J Am Acad Dermatol
; 89(4): 843-846, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343827
17.
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
J Am Acad Dermatol
; 79(6): 1081-1088, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30025829
18.
Histopathologic features and immunohistochemistry findings to assist the dermatopathologist in differentiating melanocytic matrical carcinoma from melanoma.
J Cutan Pathol
; 50(6): 471-474, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36645720
19.
Mucosal haemangioma in the setting of treatment with trastuzumab emtansine (T-DM1).
Br J Dermatol
; 187(5): e168, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35633104
20.
Consensus on the clinical management of chronic radiation dermatitis and radiation fibrosis: a Delphi survey.
Br J Dermatol
; 187(6): 1054-1056, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36047980